HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.

Abstract
The pharmacokinetics of the broad-spectrum penicillin Bay k 4999 were studied in six healthy male volunteers. A 2-g dose was given by the intravenous route. The tissue penetration of the antibiotic was studied by both dermabrasion and blister techniques. A total of 26.4% of the drug was recovered in the urine in 24 h, 79% of this being excreted in the first 2 h. The elimination half-life in serum was 1.3 h. The dermabrasion levels of Bay k 4999 were generally similar to those in serum, but after 1 h the blister fluid levels of antibiotic were greater than those in serum. Different drug levels obtained by blister and dermabrasion techniques may be due to the different composition of the two fluids.
AuthorsR Wise, B Cadge, A P Gillett, A Bhamjee, R Livingston, P G Welling, D P Thornhill
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 15 Issue 5 Pg. 670-3 (May 1979) ISSN: 0066-4804 [Print] United States
PMID525984 (Publication Type: Journal Article)
Chemical References
  • Blood Proteins
  • Imidazolidines
  • Penicillins
  • Azlocillin
  • furazlocillin
Topics
  • Adult
  • Azlocillin (analogs & derivatives)
  • Blood Proteins (metabolism)
  • Half-Life
  • Humans
  • Imidazolidines
  • Kinetics
  • Male
  • Penicillins (blood, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: